Sign Up to like & get
recommendations!
0
Published in 2021 at "International Journal of Applied Pharmaceutics"
DOI: 10.22159/ijap.2021v13i1.40113
Abstract: Objective: The current work mainly focuses on solubility enhancement of dolutegravir which is a BCS (Biopharmaceutical Classification System) class-II drug using various excipients. Methods: Solid dispersions of dolutegravir were prepared by solvent evaporation and fusion…
read more here.
Keywords:
drug;
dolutegravir;
dolutegravir solid;
solid dispersions ... See more keywords